CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...

Gujarat is leading India's solar cell manufacturing with significant investments and capacity expansions, positioning itself ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.

The production of red blood cells from stem cells has emerged as a transformative approach to address chronic blood shortages and meet the increasing demand for transfusion therapies. By harnessing ...

Reliance Industries has paused its battery manufacturing plans after failing to acquire Chinese cell technology, highlighting ...

Anza, a subscription-based data and analytics software platform, released its Q2 2025 Domestic Content Insights report that reveals trends in domestic manufacturing of solar modules and battery energy ...